))
Antibody discovery with LabGenius' James Field
Manage episode 422212455 series 3573130
内容由Balderton Capital提供。所有播客内容（包括剧集、图形和播客描述）均由 Balderton Capital 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
What do synthetic biology, machine learning and robotics have in common? James Field, CEO and founder of LabGenius, explains how his company is integrating bleeding-edge technologies from across these fields to discover the next-generation therapeutic antibodies. And change the way we approach drug discovery.
Find out more about Labgenius here and follow them on LinkedIn
章节
1. Intro (00:00:00)
2. How James’ PhD experience shaped his entrepreneurial journey (00:05:25)
3. Why grants play a crucial role for deeptech startups (00:09:50)
4. LabGenius’ fundraising experience (00:12:35)
5. On growing the team (00:17:55)
6. What does success look like for LabGenius in the next few years (00:21:05)
7. Why now is the moment for synthetic biology (00:21:59)
8. Changing scientific discovery through “silicone scientists” (00:25:00)
9. LabGenius’ relationship with the pharmaceutical industry (00:33:47)
10. Where software companies fit in (00:36:16)
11. LabGenius' ultimate dream (00:39:05)
10集单集
分享
